Exponential Biotherapies Inc is categorized under Commercial Medical Research in Port Washington, NY and active since 1993.
Exponential Biotherapies Inc was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Paul Washart, Manager at the company’s single location by writing to 150 Main St, Port Washington, New York NY 11050 or by phoning (516) 883-6884. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Exponential Biotherapies Inc |
| Contact Person: | Paul Washart, Manager |
| Address: | 150 Main St, Port Washington, New York 11050 |
| Phone Number: | (516) 883-6884 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6215110 |
| Share This Business: |
Exponential Biotherapies Inc was started in 1993 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Paul Washart, Manager for inquiries that concern Exponential Biotherapies Inc by calling the company number (516) 883-6884, as your correspondence is most welcome. Additionally, the physical location of the single location of Exponential Biotherapies Inc can be found at the coordinates 40.8305,-73.69236 as well as the street address 150 Main St in Port Washington, New York 11050.
For its online presence, you may visit Exponential Biotherapies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.